Orphan drugs will fuel pharma’s future – and a pricing pushback tooEvaluate predicts sales could approach $8bn if approved. Share XOrphan drugs will fuel pharma’s future – and a pricing pushback toohttps://pharmaphorum.com/views-and-analysis/orphan-drugs-will-fuel-pharmas-future/